Delivery of Medicinal Products Included in the List Pursuant to Art. 266a, Para. 2 of the Law on Medicinal Products for Human Use – Teduglutide

This tender concerns the supply of medicinal products, specifically Teduglutide, which is included in a designated list under Article 266a, Paragraph 2 of the Law on Medicinal Products for Human Use. Teduglutide is a medication used to treat short bowel syndrome. The procurement is likely being conducted by a healthcare provider, such as a hospital, pharmacy, or national health service, that requires this specific pharmaceutical product. The tender aims to secure a reliable supply of Teduglutide, ensuring that patients who require this treatment have access to it. The contracting entity will specify the required quantities, dosage forms, packaging, and delivery schedules. Bidders, typically pharmaceutical distributors or manufacturers, must comply with all relevant regulations governing the supply of medicines, including quality control, storage, and distribution standards. The tender process will ensure that the selected supplier can meet the necessary pharmaceutical requirements and provide the medication efficiently. This procurement is vital for patient care and treatment continuity for individuals suffering from short bowel syndrome.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Bulgaria, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.